Drug intelligence / Profile preview

Elsenz

Development stage: Unknown
Lead developer: Group Pharmaceutical
Administration: Topical

Overview

**Elsenz** is a fluoride-containing, over-the-counter remineralizing toothpaste developed and manufactured by Group Pharmaceuticals for daily management of dentin hypersensitivity and prevention of dental caries. Its principal functional ingredient is fluoro calcium phosphosilicate, a fluoride-containing bioactive glass marketed in association with BioMin F technology. On contact with saliva, the material releases fluoride, calcium, and phosphate ions that support formation of an acid-resistant fluorapatite-like mineral layer on enamel and exposed dentin, helping reduce sensitivity and protect against acid-mediated demineralization. The marketed product is a mint-flavored toothpaste paste for topical oral use.

Brand names: Elsenz
Other names: Elsenz Double Action ToothpasteElsenz Toothpaste

Beyond the preview

Go deeper on Elsenz.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elsenz.

Explore the full profile